In-depth mechanistic studies on the importance of the gut microbiome on brain health and the role of dysbiosis in the pathogenesis and progression of brain disorders will reveal potential opportunities to modify the gut microbiota with diets, pre-and pro-biotics. While it has long been suspected that dietary interventions may modify gastrointestinal function, studies demonstrating effects of the gut microbiome on microglia phenotype and neuronal development and function have taken the neuroscience field by surprise. For an in-depth review of the gut-bran axis and the role of the gut microbiome on immune cell development in the bone marrow and trafficking to the brain to effect brain function and behavior, the reader is referred to a series of recent reviews by John Cryan and colleagues . For an overview of the effects of the gut microbiome on general CNS function, development, and behavior please refer to work by Mazmanian and colleagues (Sampson and Mazmanian, 2015; Sharon et al., 2016) .
In this special issue, Caruso Flux presents the complex effects of the gut microbiome on the interplay between the immune, endocrine and nervous systems on modulating mood and resilience versus depression. Emily Severance reviews the role of the gut microbiome in schizophrenia, including evidence that suggests major histocompatibility complex (MHC) and complement genes may be playing a role in immune responses that underlie vulnerability and risk for schizophrenia and perhaps other psychiatric disorders.
Not surprisingly, in addition to the effects of disruptions in the gut microbiome on behavior and mood disorders, new evidence is arising that gut dysbiosis may also play an important role in the etiology or progression of neurodegenerative diseases. In this special issue, we have included several papers in this area. While in the Mazmanian lab, Timothy Sampson reported that gut microbiota from Parkinson's patients displays accelerating effects on synuclein brain pathology when introduced into a mouse model with genetic predisposition for Parkinson's-like pathology . In this special issue, Sampson reviews the role of indigenous microbes in the gut within the context of PD pathogenesis, including differences between gut regions, and the potential impact of known comorbidities on microbiome structures. He provides a useful summary of the primary findings from the dozen or so published PD microbiome studies to date.
J o u r n a l P r e -p r o o f
In the article by Ali Keshavarzian, the effects of chronic restraint stress on gut permeability and microbiome that occur in association with enhanced activation of brain microglia and degeneration in the midbrain dopaminergic neurons are explored in response to the pesticide rotenone which induces oxidative stress within the context of Parkinson's disease. In addition, Hertzberg and colleagues detail the gut microbiome and systemic inflammation in patients with Amyotrophic Lateral Sclerosis (ALS) and their household partners; while Hannan and Pouladi describe the effects of manipulation of the gut microbiome in a mouse model of Huntington's disease, including sex-specific differences in microbiome diversity.
Finally, Elaine Hsaio whose initial work on the role of gut microbiome in autism spectrum disorders was also developed in the Mazmanian lab, has recently expanded her focus into the field of epilepsy. In this special issue, she gives an elegant overview of the emerging role of the gut microbiome in epilepsy, on the heels of her recent work elucidating how the ketogenic diet reduces epileptogenic activity via modulation of the gut microbiome.
While we recognize that only a handful of neurological disorders are included in this special issue, on the role of microbiome in neurological disorders, it is our hope that the reader of this special issue will gain a broader understanding of the current efforts, challenges and opportunities in the field and that this knowledge will spark additional ideas and formulation of testable hypotheses to further advance the field. A better understanding of the intricate functional relationships between the gut microbiome and the brain will enable mechanism -based interventional therapies to delay, mitigate, and potentially prevent the genesis of a number of neurological disorders.
